Hippocampal glutamate levels and striatal dopamine D2/3 receptor occupancy in subjects at ultra high risk of psychosis

Biological Psychiatry

Volumn 70, Issue 1, 2011, Pages

  Bloemen, Oswald J N ^a   Gleich, Tobias ^a   De Koning, Mariken B ^a   Da Silva Alvis, Fabiana ^a   De Haan, Lieuwe ^a   Linszen, Don H ^a   Booij, Jan ^a   Van Amelsvoort, Thrse A M J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GLUTAMIC ACID; IODINE 123; IODOBENZAMIDE IODINE 123; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HUMAN; LETTER; MENTAL HEALTH; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORPUS STRIATUM; DOPAMINE; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; PSYCHOTIC DISORDERS;

EID: 79958797515     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.11.030     Document Type: Letter

References (16)

1. J.M. Stone, O.D. Howes, A. Egerton, J. Kambeitz, P. Allen, and D.J. Lythgoe Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis Biol Psychiatry 68 2010 599 602
2. A. Carlsson, N. Waters, S. Holm-Waters, J. Tedroff, M. Nilsson, and M.L. Carlsson Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence Annu Rev Pharmacol Toxicol 41 2001 237 260 (Pubitemid 32385889)
3. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, S. Heckers, and A.A. Grace Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci 31 2008 234 242
4. D.J. Lodge, and A.A. Grace The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation Neuropsychopharmacology 31 2006 1356 1361
5. J.M. Stone, P.D. Morrison, and L.S. Pilowsky Glutamate and dopamine dysregulation in schizophreniaA synthesis and selective review Psychopharmacologie 21 2007 440 452 (Pubitemid 47077295)
6. R.B. Innis, V.J. Cunningham, J. Delforge, M. Fujita, A. Gjedde, and R.N. Gunn Consensus nomenclature for in vivo imaging of reversibly binding radioligands J Cereb Blood Flow Metab 27 2007 1533 1539 (Pubitemid 47301451)
7. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, and L.S. Kegeles Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc Natl Acad Sci U S A 97 2000 8104 8109 (Pubitemid 30460780)
8. A. Abi-Dargham, E. van de Giessen, M. Slifstein, L.S. Kegeles, and M. Laruelle Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects Biol Psychiatry 65 2009 1091 1093
9. 2 receptor binding in subjects at Ultra High Risk for psychosis Presented at the Early Psychosis Association Conference, Amsterdam 2010 November 2010
10. J.M. Stone, F. Day, H. Tsagaraki, I. Valli, M.A. McLean, and D.J. Lythgoe Glutamate dysfunction in people with prodromal symptoms of psychosis: Relationship to gray matter volume Biol Psychiatry 66 2009 533 539
11. J. Booij, G. Tissingh, G.J. Boer, J.D. Speelman, J.C. Stoof, and A.G. Janssen [123 I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson;s disease J Neurol Neurosurg Psychiatry 62 1997 133 140
12. L. Voruganti, P. Slomka, P. Zabel, G. Costa, A. So, A. Mattar, and A.G. Awad Subjective effects of AMPT-induced dopamine depletion in schizophrenia: Correlation between dysphoric responses and striatal d(2) binding ratios on SPECT imaging Neuropsychopharmacology 25 2001 642 650 (Pubitemid 32995946)
13. E. Boot, J. Booij, G. Hasler, J.R. Zinkstok, H.L. de, and D.H. Linszen AMPT-induced monoamine depletion in humans: Evaluation of two alternative [123I]IBZM SPECT procedures Eur J Nucl Med Mol Imaging 35 2008 1350 1356
14. E.S. Lutkenhoff, T.G. van Erp, M.A. Thomas, S. Therman, M. Manninen, and M.O. Huttunen Proton MRS in twin pairs discordant for schizophrenia Mol Psychiatry 15 2010 308 318
15. G.E. Tsai, and P.Y. Lin Strategies to enhance N-methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis Curr Pharm Des 16 2010 522 537
16. I. Valli, J. Stone, A. Mechelli, S. Bhattacharyya, M. Raffin, and P. Allen altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis Biol Psychiatry 69 2010 97 99